Impact of Clone Size With a Single Cytogenetic Abnormality on the Revised International Prognostic Scoring System in Myelodysplastic Syndromes

American Journal of Hematology- United States

doi 10.1002/ajh.25287

Full Text

Abstract

Available in

Date

October 9, 2018

Authors

Publisher

Wiley

Related search

Cytogenetic Prognostic Factors in Myelodysplastic Syndromes

Hematology & blood transfusion: interdepartamental collection

2016

English

Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System

Journal of Clinical Oncology

English

The Myelodysplastic Syndrome-Comorbidity Index Provides Additional Prognostic Information on Patients Stratified According to the Revised International Prognostic Scoring System

Haematologica

Hematology

2014

English

Improving Revised International Prognostic Scoring System (IPSS-R) Pre-Allogeneic Stem Cell Transplant Does Not Translate Into Better Post-Transplant Outcomes for Patients With Myelodysplastic Syndromes: A Single Center Experience

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2018

English

Bone Marrow Dyspoiesis and Revised International Prognostic Scoring System- A Comparative Study

Journal of Evolution of Medical and Dental Sciences

2019

English

The 2016 Revised World Health Organization Definition of ‘Myelodysplastic Syndrome With Isolated Del(5q)’; Prognostic Implications of Single Versus Double Cytogenetic Abnormalities

British Journal of Haematology

Hematology

2017

English

The Impact of Sex on Disease Phenotype and Prognostic Thresholds of Anemia in Myelodysplastic Syndromes

American Journal of Hematology

Hematology

2018

English

Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes

Journal of Clinical Oncology

English

Cytogenetic Clonal Evolution in Myelodysplastic Syndromes Is Associated With Inferior Prognosis

English

Amanote Research

Impact of Clone Size With a Single Cytogenetic Abnormality on the Revised International Prognostic Scoring System in Myelodysplastic Syndromes

American Journal of Hematology- United States

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Cytogenetic Prognostic Factors in Myelodysplastic Syndromes

Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System

The Myelodysplastic Syndrome-Comorbidity Index Provides Additional Prognostic Information on Patients Stratified According to the Revised International Prognostic Scoring System

Improving Revised International Prognostic Scoring System (IPSS-R) Pre-Allogeneic Stem Cell Transplant Does Not Translate Into Better Post-Transplant Outcomes for Patients With Myelodysplastic Syndromes: A Single Center Experience

Bone Marrow Dyspoiesis and Revised International Prognostic Scoring System- A Comparative Study

The 2016 Revised World Health Organization Definition of ‘Myelodysplastic Syndrome With Isolated Del(5q)’; Prognostic Implications of Single Versus Double Cytogenetic Abnormalities

The Impact of Sex on Disease Phenotype and Prognostic Thresholds of Anemia in Myelodysplastic Syndromes

Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes

Cytogenetic Clonal Evolution in Myelodysplastic Syndromes Is Associated With Inferior Prognosis